FDA registered 503B human outsourcing facility

Sincerus provides sterile and non-sterile pharmaceutical compounding services to physicians, group practices, surgery centers, and hospitals.


Is your organization interested in ordering medication?

Our Strengths

Exceptional quality

We are committed to producing only the purest, safest, and most efficacious products possible, compromising nothing in the process.

Continuous improvement

We strive for perfection in every aspect of our company through the ongoing evaluation and refinement of our quality systems.

Regulatory compliance

We respect and fully comply with all local, national and international regulatory standards governing the manufacture of pharmaceuticals.

Integrity

We conduct ourselves with the highest standards, in the way we produce our product, in the way we relate to each other, our customers, our suppliers and our community.


Highest of standards

On November 27, 2013, the Drug Quality and Security Act (DQSA) was made law. This legislation contains important provisions relating to the oversight of compounding of human drugs. Specifically, it outlines critical steps to build an electronic, interoperable system to identify and trace certain prescription drugs as they are distributed in the United States. The FDA’s unprecedented level of oversight is intended to ensure drugs are compounded under CGMP and are ultimately in place to improve the quality and availability of drugs in the supply chain.

We are committed to producing only the purest, safest, and most efficacious products possible, compromising nothing in the process.